Nottingham MRI installation marks Philips' 50th in Europe
18 November 2005
Andover, Mass., USA. The installation of an Achieva 3.0T Magnetic
Resonance Imaging (MRI) compact whole-body scanner at the Queen’s Medical
Centre, Nottingham, U.K. is the 50th Achieva 3.0T sale for Philips
Medical System in Europe.
The Achieva 3.0T will be used for routine clinical applications of the
whole body, including neurological, cardiovascular, musculoskeletal and
orthopaedic imaging, beginning in November, 2005. Queen’s Medical Centre has
two 1.5T systems but this is its first 3.0T MRI system, which has been
installed with features including FreeWave 16-channel architecture and
multi-nucli spectroscopy, boosting general imaging performance and providing
extra functionality in neurological studies.
The new scanner will also be used for ongoing clinical trials and new
translational studies, which aims to apply new insights into clinical
applications, being conducted in collaboration with the University of
Nottingham’s Division of Academic Radiology and the University of Nottingham
Sir Peter Mansfield Magnetic Resonance Centre, which is already using
Philips Achieva 1.5T, 3.0T and 7.0T MRI systems.
“We are looking forward to exploiting the advanced imaging and
spectroscopic capabilities of the new Philips Achieva 3.0T in translational
research and cutting-edge patient care,” said Prof. Dorothee Auer, Head of
Academic Radiology, Queens Medical Centre.
“The ease of use, which is essential in a clinical environment, and the
advanced MR performance that our system delivers is helping growing numbers
of clinicians benefit from our 3.0T MRI,” said Jacques Coumans Ph.D., vice
president of MR global marketing for Philips Medical Systems.
The system’s SENSE parallel imaging technology means that it scans up to
eight times faster than conventional systems, providing enhanced
productivity and patient comfort. The clinical benefits include very high
signal-to-noise ratio for fast, high resolution imaging and image detail,
which supports improved diagnostic capabilities by enabling clinicians to
see anatomical structures and details that are simply not visible at lower
field strengths.
To top
|
|